These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Reinstituting warfarin in patients who develop warfarin skin necrosis. Jillella AP; Lutcher CL Am J Hematol; 1996 Jun; 52(2):117-9. PubMed ID: 8638632 [TBL] [Abstract][Full Text] [Related]
5. An unusual case of warfarin-induced pinna skin necrosis. Martinez Del Pero M; Verma S; Espeso A; Griffiths M; Jani P J Laryngol Otol; 2009 Jun; 123(6):685-8. PubMed ID: 18925999 [TBL] [Abstract][Full Text] [Related]
6. Painful plaques shortly after hospital discharge. Warfarin plaques. Graham JB; Fagan B; Latessa R Am Fam Physician; 2008 Mar; 77(5):675-6. PubMed ID: 18350767 [No Abstract] [Full Text] [Related]
9. Nonpalpable purpura within a setting of anticoagulant therapy and metastatic carcinoma. Grenier N; Chen-Tsai C Int J Low Extrem Wounds; 2006 Sep; 5(3):200-3. PubMed ID: 16928675 [TBL] [Abstract][Full Text] [Related]
10. Warfarin and heparin-induced skin necrosis and the purple toe syndrome: infrequent complications of anticoagulant treatment. Sallah S; Thomas DP; Roberts HR Thromb Haemost; 1997 Aug; 78(2):785-90. PubMed ID: 9268171 [No Abstract] [Full Text] [Related]
11. Low-molecular-weight heparin-induced skin necrosis: a potential association with pre-existent hypercoagulable states. Toll A; Gallardo F; Abella ME; Fontcuberta J; Barranco C; Pujol RM Int J Dermatol; 2005 Nov; 44(11):964-6. PubMed ID: 16336536 [No Abstract] [Full Text] [Related]
12. Warfarin-induced skin necrosis: report of four cases. Horn JR; Danziger LH; Davis RJ Am J Hosp Pharm; 1981 Nov; 38(11):1763-8. PubMed ID: 7030072 [TBL] [Abstract][Full Text] [Related]
13. Warfarin-Induced Skin Necrosis in Patients With Low Protein C Levels. Marčić M; Marčić L; Titlić M Acta Med Iran; 2016 Aug; 54(8):551-554. PubMed ID: 27701728 [TBL] [Abstract][Full Text] [Related]
15. Warfarin-induced benign acral cutaneous lesions in two cardiac patients with decreased protein C and S activity. Vural M; Usta S; Kaya R Anadolu Kardiyol Derg; 2008 Aug; 8(4):E22. PubMed ID: 18676288 [No Abstract] [Full Text] [Related]
16. Use of warfarin therapy at a target international normalized ratio of 3.0 for cutaneous polyarteritis nodosa. Kawakami T; Soma Y J Am Acad Dermatol; 2010 Oct; 63(4):602-6. PubMed ID: 20675014 [TBL] [Abstract][Full Text] [Related]